Although other biomarkers have been evaluated, including HPV status, interferon gamma (IFN-γ) signature, neutrophil to lymphocyte ratio (NLR), and the host microbiome status [9], few studies have investigated nutritional status as a potential biomarker or its effects on immunotherapy outcomes in HNSCC. This evidence concerns the gene IFNG and head and neck squamous cell carcinoma.